Skip to main content

Understand. Power. Act.

The Library

New

One story, all the way down.

FDA Says It Won’t Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns

The final review is expected more than two years after RFK Jr. and the former FDA commissioner pledged to ‘study the safety’ of abortion pills.

Sources (1)· Oct 8, 2:03 PM

fda abortion pill review delay Health

Every telling

their own versions

The Federalist· Oct 8, 2:03 PMFDA Says It Won’t Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns

More like this

similar stories in the archive

FDA says it will complete safety review of abortion pill in MarchA federal judge in Louisiana ordered the agency to provide an update on its safety study as part of a lawsuit seeking to overturn a provision allowing mifepristone to be delivered by mail.

NBC News1d agoSources (2)Whole story →

Health abortion pill safety review

FDA says its review of abortion pill will continue into next yearThe Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year

ABC News2d agoWhole story →

Health abortion pill review

FDA: Mifepristone review won't be done until MarchThe Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion activists, who have been losing patience with the...

The Hill2d agoWhole story →

Health mifepristone fda review

Trump Finally Gives Update on Deadly Drug—Why Its Opponents Are Not HappyThe Food and Drug Administration plans to complete its long-awaited review of abortion drugs in mid-December, but the public won’t see the results until March, according to a Wednesday filing from the Justice Department. The 5th Circuit Court ordered the FDA to provide an update on its abortion pill safety review by Oct. 7, after...

The Daily Signal1d agoWhole story →

Government abortion pill review update

Feds unlikely to change abortion pill policy before next yearThe U.S. Food and Drug Administration said late Wednesday that it expects to complete its long-awaited safety review of abortion pills by mid-December and issue a report evaluating the results by March 2027. The agency disclosed the information in a court-mandated status report it submitted in the federal lawsuit Louisiana v. FDA. The timeline aligns […]

Stateline1d agoWhole story →

Health abortion pill policy review

Senators to question FDA nominee about her views on abortion pill and vaccinesPresident Donald Trump’s pick to run the Food and Drug Administration will face questions from Senate lawmakers considering her nomination.

WDIV ClickOnDetroit15d agoWhole story →

Government Donald Trump Bill Cassidy fda nominee hearing

Trump's FDA pick to face vaccine, abortion pill questions at US Senate hearingThe US Senate health committee will hold a confirmation hearing on Thursday for Heidi Overton, President Donald ‌Trump's pick to lead the embattled FDA, as it also weighs advancing his surgeon general nominee.

Reuters15d agoSources (2)Whole story →

Health fda confirmation hearing

Trump admin reveals post-midterm ‘crackdown’ plans in new court filing: reportThe Trump administration is laying the groundwork for a “post-midterm crackdown” on abortion medication, according to Talking Points Memo, which reported that a new court filing details its review of mifepristone. TPM’s Kate Riga described the effort as a coming “attack” that has been “deliberately delayed to avoid midterm backlash.” The filing places…

Raw Story22h agoWhole story →

Health abortion medication review